Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer’s Disease: An Updated Overview of Its Genetics
Jesús Andrade-Guerrero, Alberto Santiago-Balmaseda, Paola Jeronimo-Aguilar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3754-3754
Open Access | Times Cited: 170

Showing 1-25 of 170 citing articles:

Exosome-Based Drug Delivery: Translation from Bench to Clinic
Hee Byung Koh, Hyo Jeong Kim, Shin‐Wook Kang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2042-2042
Open Access | Times Cited: 76
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Julia Odum, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16288-16288
Open Access | Times Cited: 58
Review of Pharmacotherapeutic Targets in Alzheimer’s Disease and Its Management Using Traditional Medicinal Plants
Prabhash Nath Tripathi, Ankit Lodhi, Sachchida Nand, et al.
Degenerative Neurological and Neuromuscular Disease (2024) Vol. Volume 14, pp. 47-74
Open Access | Times Cited: 44
Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Caterina Peggion, Tito Calì, Marisa Brini
Antioxidants (2024) Vol. 13, Iss. 2, pp. 240-240
Open Access | Times Cited: 25
Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
Ernesto Fedele
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14499-14499
Open Access | Times Cited: 32
Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches
Amirreza Gholami
Neuroscience Letters (2023) Vol. 817, pp. 137532-137532
Closed Access | Times Cited: 22
A hybrid multimodal machine learning model for Detecting Alzheimer's disease
Jinhua Sheng, Qian Zhang, Qiao Zhang, et al.
Computers in Biology and Medicine (2024) Vol. 170, pp. 108035-108035
Closed Access | Times Cited: 14
Review on anti-alzheimer drug development: approaches, challenges and perspectives
Abdallah E. Abdallah
RSC Advances (2024) Vol. 14, Iss. 16, pp. 11057-11088
Open Access | Times Cited: 14
Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Enjie Liu, Yao Zhang, Jian–Zhi Wang
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Recent advancement in understanding of Alzheimer's disease: Risk factors, subtypes, and drug targets and potential therapeutics
Sneh Prabha, Mohd Sajad, Gulam Mustafa Hasan, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102476-102476
Closed Access | Times Cited: 13
Extra-Virgin Olive Oil in Alzheimer’s Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies
Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Amal Kaddoumi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1914-1914
Open Access | Times Cited: 12
Promoting Alzheimer’s disease research and therapy with stem cell technology
Zimeng Cao, Fanshu Kong, Jiaqi Ding, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Schizophrenia genomics: genetic complexity and functional insights
Patrick F. Sullivan, Shuyang Yao, Jens Hjerling‐Leffler
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 9, pp. 611-624
Closed Access | Times Cited: 11
Alzheimer’s Disease as Type 3 Diabetes: Understanding the Link and Implications
Mateusz Kciuk, Weronika Kruczkowska, Julia Gałęziewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11955-11955
Open Access | Times Cited: 11
Neuroinflammaging: A Tight Line Between Normal Aging and Age-Related Neurodegenerative Disorders
Luca Soraci, Andrea Corsonello, Ersilia Paparazzo, et al.
Aging and Disease (2024)
Open Access | Times Cited: 10
Genomic stress and impaired DNA repair in Alzheimer disease
Jolien Neven, Luidy Kazuo Issayama, Ilse Dewachter, et al.
DNA repair (2024) Vol. 139, pp. 103678-103678
Closed Access | Times Cited: 9
Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies
Manish Kumar Singh, Yoonhwa Shin, Songhyun Ju, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6901-6901
Open Access | Times Cited: 9
From Lab Bench to Hope: Emerging Gene Therapies in Clinical Trials for Alzheimer’s Disease
Angélica Ortega-Torres, Brendan Chernicki, Grace Ou, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 9
Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
Devika Jadhav, Nikita Saraswat, Neeraj S. Vyawahare, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2024) Vol. 60, Iss. 1
Open Access | Times Cited: 8
The associations of serum vitamin D status and vitamin D supplements use with all-cause dementia, Alzheimer’s disease, and vascular dementia: a UK Biobank based prospective cohort study
Li‐Ju Chen, Sha Sha, Hannah Stocker, et al.
American Journal of Clinical Nutrition (2024) Vol. 119, Iss. 4, pp. 1052-1064
Open Access | Times Cited: 8
Anti-Amyloid Therapies for Alzheimer’s Disease and Amyloid-Related Imaging Abnormalities: Implications for the Emergency Medicine Clinician
Megan A. Rech, Christopher R. Carpenter, Neelum T. Aggarwal, et al.
Annals of Emergency Medicine (2025)
Closed Access | Times Cited: 1
Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
Sahar Balkhi, Antimo Di Spirito, Alessandro Poggi, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 264-264
Open Access | Times Cited: 1
Unlocking ocular biomarkers for early detection of Alzheimer's disease
Nikhil Dave, Melissa Lee, H Pavlou, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 1
Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration
Jannis Kountouras, Michael Doulberis, Apostolis Papaefthymiou, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 504-504
Open Access | Times Cited: 18
Targeting epigenetics: A novel promise for Alzheimer’s disease treatment
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2023) Vol. 90, pp. 102003-102003
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top